BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31864009)

  • 1. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
    Ogier JM; Lockhart PJ; Burt RA
    Hear Res; 2020 Feb; 386():107870. PubMed ID: 31864009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative ototoxicity of aminoglycoside antibiotics in a guinea pig model (author's transl)].
    Brummett RE
    Nouv Presse Med; 1978 Nov; 7(42):3849-53. PubMed ID: 568779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ototoxicity of the aminoglycoside antibiotics (author's transl)].
    Federspil P
    Infection; 1976; 4(4):239-48. PubMed ID: 1017884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice.
    Murillo-Cuesta S; Contreras J; Cediel R; Varela-Nieto I
    Lab Anim; 2010 Apr; 44(2):124-31. PubMed ID: 19858169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dosing schedule on aminoglycoside ototoxicity: comparative cochlear ototoxicity of amikacin and isepamicin.
    Takumida M; Nishida I; Nikaido M; Hirakawa K; Harada Y; Bagger-Sjöbäck D
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(6):341-9. PubMed ID: 2274318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetical, histological, and histochemical investigation on the ototoxicity of gentamicin, tobramycin, and amikacin (author's transl)].
    Federspil P; Schätzle W; Tiesler E
    Arch Otorhinolaryngol; 1977 Jul; 217(2):147-66. PubMed ID: 578730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin.
    Garinis A; Gleser M; Johns A; Larsen E; Vachhani J
    J Cyst Fibros; 2021 Mar; 20(2):278-283. PubMed ID: 32713806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
    Zadrożniak M; Szymański M; Łuszczki JJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin C alleviates ototoxic effect caused by coadministration of amikacin and furosemide.
    Zadrozniak M; Szymanski M; Luszczki JJ
    Pharmacol Rep; 2019 Apr; 71(2):351-356. PubMed ID: 30831441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine chloride protects cochlear hair cells from aminoglycoside-induced ototoxicity by reducing the accumulation of mitochondrial reactive oxygen species.
    Kim YR; Baek JI; Lee KY; Kim UK
    Free Radic Biol Med; 2023 Aug; 204():177-183. PubMed ID: 37119862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ototoxic drugs. I. Aminoglycoside antibiotics].
    Buszman E; Wrześniok D; Matusiński B
    Wiad Lek; 2003; 56(5-6):254-9. PubMed ID: 14526485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.
    Harruff EE; Kil J; Ortiz MGT; Dorgan D; Jain R; Poth EA; Fifer RC; Kim YJM; Shoup AG; Flume PA
    J Cyst Fibros; 2021 Mar; 20(2):288-294. PubMed ID: 33341407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-protection against aminoglycoside ototoxicity in guinea pigs.
    Oliveira JA; Canedo DM; Rossato M; Andrade MH
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):271-9. PubMed ID: 15365547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sound preconditioning therapy inhibits ototoxic hearing loss in mice.
    Roy S; Ryals MM; Van den Bruele AB; Fitzgerald TS; Cunningham LL
    J Clin Invest; 2013 Nov; 123(11):4945-9. PubMed ID: 24216513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of neomycin, tobramycin and amikacin with melanin in vitro in relation to aminoglycosides-induced ototoxicity.
    Buszman E; Wrześniok D; Trzcionka J
    Pharmazie; 2007 Mar; 62(3):210-5. PubMed ID: 17416198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative surface studies of ototoxic effects of various aminoglycoside antibiotics on the organ of Corti in the guinea pig. A scanning electron microscopic study.
    Theopold HM
    Acta Otolaryngol; 1977; 84(1-2):57-64. PubMed ID: 899753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebselen attenuates tobramycin-induced ototoxicity in mice.
    Gu R; Longenecker RJ; Homan J; Kil J
    J Cyst Fibros; 2021 Mar; 20(2):271-277. PubMed ID: 32147183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside-induced ototoxicity.
    Selimoglu E
    Curr Pharm Des; 2007; 13(1):119-26. PubMed ID: 17266591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.